EUVIMEDEUVIMED entdecken
Fallbericht

Resolution of severe neurobehavioral difficulties in an individual with Primrose syndrome with sertraline

Young Min Moon iD, Sa Eun Park, Constance Smith-Hicks iD, Aaron Hauptman

American Journal of Medical Genetics Part A · 2024

DOI: 10.1002/ajmg.a.63610 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Young Min Moon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Sertraline, Intellectual Disability, Transcription Factors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primrose syndrome (PS) is a rare genetic disease characterized by developmental delay, intellectual disability, sensorineural hearing loss, and dysmorphic features. PS is caused by de novo pathogenic variants in the ZBTB20 gene, which encodes a transcription factor modulating neurogenesis. We describe resolution with sertraline of neurobehavioral difficulties in a 17‐year‐old Hispanic male with PS with de novo heterozygous c.1916G > A (p.C639Y) variant of ZBTB20 . Neurobehavioral difficulties included aggression towards self and others, irritability, tearfulness, and mood liability that did not respond to behavioral interventions or aripiprazole. Treatment with sertraline, a medication indicated for psychiatric disorders including anxiety and depression, led to the resolution of neurobehavioral difficulties after 2 weeks of initiation of medication. The treatment course suggests that selective serotonin reuptake inhibitors, such as sertraline, may be a useful tool for neurobehavioral difficulties in PS over antipsychotics that are accompanied by complex side effect profiles, and suggest that anxiety is the primary cause of the neurobehavioral difficulties in this patient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SertralineIntellectual DisabilityTranscription FactorsHumansMaleAdolescentHearing Loss, SensorineuralSelective Serotonin Reuptake InhibitorsAbnormalities, MultipleCalcinosisEar DiseasesMuscular AtrophyNerve Tissue Proteins

Stichwörter der Autor:innen

Primrose syndromeZBTB20anxietyneurobehavioral symptomsneuropsychiatrysertraline

Substanzen

SertralineTranscription FactorsZBTB20 protein, humanSelective Serotonin Reuptake InhibitorsNerve Tissue Proteins

Autor:innen und Institutionen

  • Department of Psychiatry, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Department of Psychiatry, Kennedy Krieger Institute, Baltimore, Maryland, USA.
  • Department of Neurology, School of Medicine, Johns Hopkins Univerisity, Baltimore, Maryland, USA.
  • Department of Neurology, Kennedy Krieger Institute, Baltimore, Maryland, USA.

ORCID-Profile: Young Min Moon, Constance Smith-Hicks

Zitieren

APA

Moon, Y. M., Park, S. E., Smith-Hicks, C., & Hauptman, A. (2024). Resolution of severe neurobehavioral difficulties in an individual with Primrose syndrome with sertraline. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63610

Vancouver

Moon YM, Park SE, Smith-Hicks C, Hauptman A. Resolution of severe neurobehavioral difficulties in an individual with Primrose syndrome with sertraline. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63610

BibTeX
@article{Moon2024,
  author = {Moon, Young Min and Park, Sa Eun and Smith-Hicks, Constance and Hauptman, Aaron},
  title = {Resolution of severe neurobehavioral difficulties in an individual with Primrose syndrome with sertraline},
  journal = {American Journal of Medical Genetics Part A},
  year = {2024},
  doi = {10.1002/ajmg.a.63610}
}
Kostenlos starten →